James Humphries

James is a chemical biologist with a research focus on developing molecular imaging-based readouts for therapeutic efficacy. He has extensive experience in radiolabelling and quality assurance development for novel radiotheranostics, as well as in molecular imaging.

James’ research focuses on developing PET and SPECT based molecular imaging protocols that can longitudinally monitor immunologically derived responses to a range of therapeutics, including radiopharmaceuticals. Concurrently to this, he is interested in developing small animal oncology models that better replicate the manifestation of human disease, as this is a critical to developing therapies that are effective in humans.

View All People